Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07503613
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Sponsor: Akouos, Inc.
View on ClinicalTrials.gov
Summary
This multi-center, observational, post-intervention LTFU study will monitor for safety and efficacy of AAVAnc80- antiVEGF in individuals with vestibular schwannoma who have previously received an intracochlear administration of AAVAnc80-antiVEGF in an interventional clinical trial
Official title: An Evaluation of the Long Term Safety and Efficacy of AAVAnc80-antiVEGF Gene Therapy in Individuals With Vestibular Schwannoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-03-02
Completion Date
2040-04
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Locations (1)
University of Texas Southwestern
Dallas, Texas, United States